Related Experiment Videos
Human ovarian tissue cultures: extracellular matrix composition, coating density and tissue dimensions
Jennifer E Scott1, Inger B Carlsson, Barry D Bavister
1Karolinska Institutet, Department of Obstetrics and Gynaecology, Karolinska University Hospital Huddinge, S-141 86 Stockholm, Sweden.
Reproductive Biomedicine Online
|September 9, 2004
Summary
Cryopreserved human ovarian tissue shows improved follicle restoration using in-vitro culture. Cubed tissue on diluted Matrigel supports better follicle viability and growth for fertility preservation.
Area of Science:
- Reproductive Biology
- Cell Culture Technology
- Fertility Preservation
Background:
- Human ovarian tissue cryopreservation is established for fertility preservation.
- Reliable restoration methods, including in-vitro follicle culture, are crucial for optimal use.
- Existing culture systems require improvements in handling and techniques.
Purpose of the Study:
- To optimize in-vitro culture techniques for human ovarian follicles.
- To investigate the impact of tissue dimensions and extracellular matrix properties on follicle viability and growth.
- To enhance the recovery and development of follicles from cryopreserved ovarian tissue.
Main Methods:
- Ovarian biopsies from 33 women were cultured for 7-14 days on extracellular matrix.
- Studies evaluated tissue dimensions (slices vs. cubes), extracellular matrix coating density, and composition.
- Follicle viability and growth activation were assessed compared to uncultured tissue.
Main Results:
- Cubed ovarian tissue showed higher viable follicle numbers and earlier growth activation (7 days) compared to slices (14 days).
- A diluted Matrigel coating supported a greater proportion of viable follicles in 7-day cultures.
- Extracellular matrix composition did not significantly affect follicle viability.
Conclusions:
- Human ovarian follicles can grow and develop in vitro within cortical tissue.
- Culturing ovarian tissue as cubes on diluted Matrigel may improve follicle recovery and growth.
- Further optimization is needed before clinical application for frozen human ovarian tissue.